Table 2.
STEMI |
NSTEMI |
|||||
---|---|---|---|---|---|---|
Previous Stroke | No Previous Stroke | p Value | Previous Stroke | No Previous Stroke | p Value | |
Aspirin | 97.3% | 98.5% | 0.0420 | 95.0% | 97.0% | <0.0001 |
Clopidogrel | 81.2% | 88.0% | <0.0001 | 57.1% | 61.6% | 0.0002 |
β Blocker | 95.2% | 96.6% | 0.0561 | 92.5% | 93.6% | 0.0741 |
Angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker | 54.7% | 58.4% | 0.0744 | 55.1% | 51.0% | 0.0002 |
Statin | 62.4% | 68.9% | 0.0001 | 57.2% | 59.2% | 0.0994 |
Glycoprotein Iib/IIIa inhibitor | 60.9% | 76.2% | <0.0001 | 32.0% | 46.8% | <0.0001 |
Unfractionated heparin | 72.6% | 79.2% | <0.0001 | 54.2% | 56.9% | 0.0139 |
Low-molecular-weight heparin | 19.9% | 16.0% | 0.0035 | 40.7% | 40.6% | 0.8937 |
Direct thrombin inhibitor | 12.2% | 10.9% | 0.1444 | 9.7% | 11.9% | 0.0051 |
Medication overdose | ||||||
Unfractionated heparin | — | — | — | 30.3% | 27.2 | 0.0231 |
Low-molecular-weight heparin | — | — | — | 13.8% | 13.5% | 0.8271 |
Glycoprotein IIb/IIIa inhibitor | 24.1% | 8.2% | <0.0001 | 20.6% | 9.7% | <0.0001 |